3,049
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Uveitic Ocular Hypertension and Glaucoma

, MD, PhD, MPH & , MD

References

  • Baneke AJ, Lim KS, Stanford M. The pathogenesis of raised intraocular pressure in Uveitis. Curr Eye Res. 2016;41(2):137–149.
  • Muñoz-Negrete FJ, Moreno-Montañés J, Hernández-Martínez P, Rebolleda G. Current approach in the diagnosis and management of Uveitic glaucoma. Biomed Res Int. 2015;2015:742792. doi: 10.1155/2015/742792. Epub 2015 Oct 19.
  • Sng CC, Ang M, Barton K. Uveitis and glaucoma: new insights in the pathogenesis and treatment. Prog Brain Res. 2015;221:243–269. doi: 10.1016/bs.pbr.2015.06.008. Epub 2015 Oct 1.
  • Sayed MS, Lee RK. Current management approaches for uveitic glaucoma. Int Ophthalmol Clin. 2015 Summer;55(3):141–160.
  • Siddique SS, Suelves AM, Baheti U, Foster CS. Glaucoma and uveitis. Surv Ophthalmol. January-February, 2013;58(1):1–10.
  • Zelefsky JR, Cunningham ET Jr. Evaluation and management of elevated IOP in patients with Uveitis. Am Acad Ophthalmol. Focal Points, June, 2010; XXVIII, 6 (Section 3 of 3).
  • Pleyer U, Ruokonen P, Heinz C, Heiligenhaus A. Intraocular pressure related to uveitis. Ophthalmologe. May, 2008;105(5):431–437.
  • Tran VT, Mermoud A, Herbort CP. Appraisal and management of ocular hypotony and glaucoma associated with uveitis. Int Ophthalmol Clin. 2000;40:175–203.
  • Moorthy RS, Mermoud A, Baerveldt G, Minckler DS, Lee PP, Rao NA. Glaucoma associated with uveitis. Surv Ophthalmol. 1997;41:361–394.
  • Kempen JH, Daniel E, Gangaputra S, et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the systemic immunosuppressive therapy for eye diseases (SITE) cohort study. Ophthalmic Epidemiol. 2008;15(1):47–55.
  • Kothari S, Foster CS, Pistilli M, et al. Systemic immunosuppressive therapy for eye diseases research group. The risk of intraocular pressure elevation in pediatric noninfectious Uveitis. Ophthalmology. 2015;122(10):1987–2001. doi:10.1016/j.ophtha.2015.06.041. Epub 2015 Jul 30.
  • Daniel E, Pistilli M, Kothari S, et al. Systemic immunosuppressive therapy for eye diseases research group. Risk of ocular hypertension in adults with noninfectious Uveitis. Ophthalmology. August, 2017;124(8):1196–1208. doi:10.1016/j.ophtha.2017.03.041. Epub 2017 Apr 19.
  • Dick AD, Tundia N, Sorg R, Zhao C, Chao J, Joshi A, Skup M. Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. Ophthalmology. Mar, 2016;123(3):655–662.
  • Sharon Y, Friling R, Luski M, Campoverde BQ, Amer R, Kramer M. Uveitic glaucoma: long-term clinical outcome and risk factors for progression. Ocul Immunol Inflamm. 2017;25(6):7404–747. doi:10.1080/09273948.2016.1255341.
  • Veerappan M, Fleischman D, Ulrich JN, Stinnett SS, Jaffe GJ, Allingham RR. The relationship of vogt-koyanagi-harada syndrome to ocular hypertension and glaucoma. Ocul Immunol Inflamm. 2017; 25(6): 20:748–752. doi:10.1080/09273948.2016.1189578.
  • Toniolo JT, Hall AJ, Smith JG, Levy J, Lim LL. Risk factors for glaucoma in a cohort of patients with fuchs heterochromic iridocyclitis. Ocul Immunol Inflamm. 2017; 25(6): 5:753–759. doi:10.1080/09273948.2016.1199712.
  • Voykov B, Doycheva D, Deuter C, Ma L, Dimopoulos S, William A. Outcomes of Ahmed glaucoma valve implantation for glaucoma secondary to fuchs Uveitis syndrome. Ocul Immunol Inflamm. 2017; 25(6): 18:760–766. doi:10.3109/09273948.2016.1168454.
  • Dhanireddy S, Kombo NC, Payal AR, Freitas-Neto CA, Preble J, Foster CS. The ex-PRESS glaucoma filtration device implantation in Uveitic glaucoma. Ocul Immunol Inflamm. 2017; 25(6):767–774. doi:10.1080/09273948.2016.1175639.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.